Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin vs EC-T in TNBC
NCT01150513Phase 3Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jun 2009
- Primary completion
- Jan 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in triple-negative breast cancer (TNBC), sponsored by Chinese Academy of Medical Sciences. Started Jun 2009; status: completed.
02
Drugs
carboplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01150513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01150513.